CLINICAL_TRIALS
trial_result
· 2026-02-18
Clinical Trial Update: A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure [Phase 2]
Summary
Phase 2 study of AZD0780 evaluating effect on ambulatory blood pressure in patients with atherosclerotic cardiovascular disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Atherosclerotic Cardiovascular Disease | Phase 2 | Status: COMPLETED